John Kruba
Family Medicine · Palm Springs, CANPI 1922092923
Payments from drug & device makers
Across 98 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$234
- Johnson & Johnson$220
- GSK$217
- Viiv Healthcare Company$133
- AstraZeneca$129
- Pfizer$111
- plus $567 from 16 others
What the payments were for
- Food & beverage$1,56397%
- Education$483%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 10 | $234 |
| Johnson & Johnson(2 entities) | 14 | $220 |
| GSK | 12 | $217 |
| Viiv Healthcare Company | 12 | $133 |
| AstraZeneca | 10 | $129 |
| Pfizer | 6 | $111 |
| Novartis | 5 | $76 |
| Merck | 4 | $72 |
| Novo Nordisk | 4 | $70 |
| Boehringer Ingelheim | 3 | $57 |
| Amgen(2 entities) | 3 | $47 |
| AbbVie | 3 | $45 |
| Astellas Pharma US Inc | 2 | $41 |
| Theratechnologies Inc. | 2 | $32 |
| Bayer | 1 | $23 |
| Therapeuticsmd, Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| EMD Serono, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Napo Pharmaceuticals Inc | 1 | $12 |
| Antares Pharma, Inc. | 1 | $11 |
How this compares
$1,612 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 234 | $1,107,361 |
| DescovyEmtricitabine/Tenofov Alafenam | 147 | $389,556 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 60 | $306,462 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 48 | $193,304 |
| TivicayDolutegravir Sodium | 76 | $192,526 |
| JulucaDolutegravir/Rilpivirine | 40 | $184,470 |
| Egrifta SvTesamorelin Acetate | 19 | $156,777 |
| PrezcobixDarunavir/Cobicistat | 54 | $137,819 |
| EliquisApixaban | 125 | $121,050 |
| OzempicSemaglutide | 41 | $71,290 |
| JardianceEmpagliflozin | 45 | $59,855 |
| CompleraEmtricita/Rilpivirine/Tenof Df | 13 | $53,701 |
| JanuviaSitagliptin Phosphate | 43 | $53,483 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 62 | $46,755 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 11 | $41,437 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy, Genvoya | $234 | $1,803,378441 claims |
| Viiv Healthcare CompanyTivicay, Juluca, Triumeq | $133 | $418,432127 claims |
| Johnson & JohnsonPrezcobix, Complera | $220 | $191,52067 claims |
| Theratechnologies Inc.Egrifta Sv | $32 | $156,77719 claims |
| PfizerEliquis | $111 | $121,050125 claims |
| Novo NordiskOzempic, Xultophy 100-3.6 | $70 | $87,15854 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $57 | $72,73469 claims |
| GSKAnoro Ellipta, Trelegy Ellipta | $217 | $66,40783 claims |
| MerckJanuvia | $72 | $53,48343 claims |
| Astellas Pharma US IncMyrbetriq | $41 | $21,40521 claims |
| AbbVieLinzess | $45 | $12,99613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,533 family medicine providers in California.
Other family medicine in Palm Springs
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.